# Hims & Hers Health, Inc. (HIMS): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Hims & Hers Health, Inc. (HIMS) is 26/100, ranked against 24,000+ stocks in 35 markets (Quality 46, Value 23, Momentum 41, each scored against its sector).

- StockRank: 26/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 46, Value 23, Momentum 41: each a 0-100 percentile within Healthcare.
- Position: #19,665 overall, #1,734 in Healthcare.
- Listing: United States, NYQ; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 27.59 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 1.2M; directors sold USD 9.8M.

Source: https://moatmap.ai/stock/HIMS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker